Stocks capped a choppy day of trading on Wall Street with more losses Thursday after an early big tech rally faded and a ...

Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.

The FDA issued a complete response letter for Regeneron's lymphoma drug odronextamab. Elsewhere, Bristol Myers raised its ...

The letters demand US drug prices match or undercut global lows, triggering a 60-day compliance timeline, and prompting ...